Reuters logo
BRIEF-FDA warns about serious liver injury with Ocaliva for rare chronic liver disease
September 21, 2017 / 4:20 PM / a month ago

BRIEF-FDA warns about serious liver injury with Ocaliva for rare chronic liver disease

Sept 21 (Reuters) - U.S. Food and Drug Administration (FDA):

* FDA warns about serious liver injury with Ocaliva for rare chronic liver disease

* Says Ocaliva (Obeticholic Acid) medicine of Intercept Pharmaceuticals being incorrectly dosed in some patients Source text: (bit.ly/2hjNpKv) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below